LongCovid
An excelent systematic review of trials currently investigating treatment for Post-Acute COVID Syndrome (PACS)/longCOVID has been published by the Clinical Microbiology and Infection (CMI).
The review identified 388 registered trials exploring 144 unique interventions for PACS. Most target general alleviation of symptoms. As highlighted by this review, there is an urgent need for further high-quality and methodologically robust PACS treatment trials.
This new review article published by the Molecular Psychiatry journal presents an overview of Published epidemiology, symptoms, and risk factors of Long COVID. This review also summarises potential pathophysiological mechanisms and biomarkers for precise prevention,…
Federal Minister of Health Prof. Dr. Karl Lauterbach just announced 150 million euros for Long Covid research in Germany for the coming years. According to Lauterbach, in addition to 100…
The Long COVID project just launched its 4th Press Release. In this PR, the Long COVID project celebrates its half-time milestone and presents an overview of the published…
In a study recently published study, researchers from the University of New South Wales and St. Vincent’s Hospital have identified a key pathway, involved in inflammation, which appears…